Genetic modification of cerebral arterial wall: Implications for prevention and treatment of cerebral vasospasm

Neurological Research

Volumn 28, Issue 7, 2006, Pages 759-768

  Vijay, Anantha ^a   Santhanam, R ^a   Katusic, Zvonimir S ^a  

^a Mayo Clinic   (United States)

Author keywords

Adenovirus; Endothelial nitric oxide synthase; Progenitor cells; Subarachnoid hemorrhage

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA GALACTOSIDASE; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ERYTHROPOIETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPROTECTIVE AGENT; RECOMBINANT ENZYME; SUPEROXIDE DISMUTASE;

BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN VASOSPASM; CELL BASED GENE THERAPY; DNA MODIFICATION; GENE TARGETING; GENE TRANSFER; HUMAN; NONHUMAN; REVIEW; STEM CELL; SUBARACHNOID HEMORRHAGE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CEREBRAL ARTERIES; ENDOTHELIN-1; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REGENERATION; STEM CELLS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 33750458365     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X152034     Document Type: Review

References (102)

1. Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part I: Incidence and effects. J Clin Neurosci 1994; 1: 19-26
2. Khurana VG, Katusic ZS. Gene transfer for cerebrovascular disease. Curr Cardiol Rep 2001; 3: 10-16
3. Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke 1996; 27: 1688-1693
4. Khurana VG, Meyer FB. Translational paradigms in cerebrovascular gene transfer. J Cereb Blood Flow Metab 2003; 23: 1251-1262
5. Chen AF, O'Brien T, Katusic ZS. Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system. Trends Pharmacol Sci 1998; 19: 276-286
6. Chen AF, Jiang SW, Crotty TB, et al. Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci USA 1997; 94: 12568-12573
7. Ooboshi H, Welsh MJ, Rios CD, et al. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res 1995; 77: 7-13
8. Kim S, Lin H, Barr E, et al. Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 1997; 100: 1006-1014
9. Toyoda K, Andresen JJ, Zabner J, et al. Calcium phosphate precipitates augment adenovirus-mediated gene transfer to blood vessels in vitro and in vivo. Gene Ther 2000; 7: 1284-1291
10. Toyoda K, Nakane H, Heistad DD. Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo. J Cereb Blood Flow Metab 2001; 21: 1125-1131
11. Khurana VG, Weiler DA, Witt TA, et al. A direct mechanical method for accurate and efficient adenoviral vector delivery to tissues. Gene Ther 2003; 10: 443-452
12. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-982
13. Faraci FM, Brian JE, Jr. Nitric oxide and the cerebral circulation. Stroke 1994; 25: 692-703
14. Katusic ZS, Milde JH, Cosentino F, et al. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke 1993; 24: 392-399
15. Chen AF, O'Brien T, Tsutsui M, et al. Expression and function of recombinant endothelial nitric oxide synthase gene in canine cerebral artery. Circ Res 1997; 80: 327-335
16. Onoue H, Tsutsui M, Smith LA, et al. Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 1998; 29: 1959-1966
17. Khurana VG, Smith LA, Weiler DA, et al. Adenovirus-mediated gene transfer to human cerebral arteries. J Cereb Blood Flow Metab 2000; 20: 1360-1371
18. Luders JC, Weihl CC, Lin G, et al. Adenoviral gene transfer of nitric oxide synthase increases blood flow in rats. Neurosurgery 2000; 47: 1206-1215
19. Khurana VG, Smith LA, Baker TA, et al. Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 2002; 33: 782-789
20. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601
21. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605
22. Scotland RS, Morales-Ruiz M, Chen Y, et al. Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ Res 2002; 90: 904-910
23. Akiyama M, Eguchi D, Weiler D, et al. Expression and function of recombinant S1179D endothelial nitric oxide synthase in canine cerebral arteries. Stroke 2002; 33: 1071-1076
24. Sorenson J, Santhanam AVR, Smith LA, et al. Expression and function of recombinant S1179D endothelial nitric oxide synthase in human pial arteries. Stroke 2005; 36: 158-160
25. Santhanam AVR, Smith LA, Akiyama M, et al. Role of endothelial nitric oxide synthase phosphorylation in cerebrovascular protective effect of erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 2005; 36: 2731-2737
26. Eguchi D, d'Uscio LV, Wambi C, et al. Inhibitory effect of recombinant iNOS gene expression on vasomotor function of canine basilar artery. Am J Physiol Heart Circ Physiol 2002; 283: H2560-H2566
27. Gunnett CA, Lund DD, Chu Y, et al. NO-dependent vasorelaxation is impaired after gene transfer of inducible NO-synthase. Arterioscler Thromb Vasc Biol 2001; 21: 1281-1287
28. Gunnett CA, Lund DD, Howard MA 3rd, et al. Gene transfer of inducible nitric oxide synthase impairs relaxation in human and rabbit cerebral arteries. Stroke 2002; 33: 2292-2296
29. Katusic ZS. Vascular endothelial dysfunction: Does tetrahydrobiopterin play a role? Am J Physiol 2001; 281: H981-H986
30. Dumont AS, Dumont RJ, Lin C, et al. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 2003; 53: 123-135
31. Beasley D, Cohen RA, Levinsky NG. Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am J Physiol 1990; 258: H1187-H1192
32. Parker JL, Adams HR. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 1993; 72: 539-551
33. Horky LL, Pluta RM, Boock RJ, et al. Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 1998; 88: 298-303
34. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-982
35. Pluta RM, Afshar JK, Boock RJ, et al. Temporal changes in perivascular concentration of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg 1998; 88: 557-561
36. Mori T, Nagata K, Town T, et al. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke 2001; 32: 636-642
37. Marks GS, Brien JF, Nakatsu K, et al. Does carbon monoxide have a physiological function? Trends Pharmacol Sci 1991; 12: 185-188
38. Stocker R, Yamamoto Y, Mcdonagh EF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046
39. Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: A putative neural messenger. Science 1993; 259: 381-384
40. Matz P, Turner C, Weinstein PR, et al. Heme oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res 1996; 713: 211-222
41. Kuroki M, Kanamaru K, Suzuki H, et al. Effect of vasospasm on heme oxygenases in a rat model of subarachnoid hemorrhage. Stroke 1998; 29: 683-689
42. Suzuki H, Kanamaru K, Tsunoda H, et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 1999; 104: 59-66
43. Eguchi D, Weiler D, Alam J, et al. Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction. J Cereb Blood Flow Metab 2001; 21: 1215-1222
44. Ono S, Komuro T, Macdonald RL. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 2002; 96: 1094-1102
45. Kim DE, Suh YS, Lee MS, et al. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 2002; 33: 2687-2691
46. Kamii H, Kato I, Kinouchi H, et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 1999; 30: 867-872
47. McGirt MJ, Parra A, Sheng H, et al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke 2002; 33: 2317-2323
48. Shishido T, Suzuki R, Qian L, et al. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke 1994; 25: 864-868
49. Macdonald RL, Weir BK, Runzer TD, et al. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery 1992; 30: 529-539
50. Kajita Y, Suzuki Y, Oyama H, et al. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 1994; 80: 476-483
51. Watanabe Y, Chu Y, Andresen JJ, et al. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003; 34: 434-440
52. Yamaguchi M, Zhou C, Heistad DD, et al. Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2004; 35: 2512-2517
53. + channels. Nature 1990; 344: 770-773
54. + channels in CGRP-induced dilatation of basilar artery in vivo. Am J Physiol 1993; 265: H581-H585
55. Nozaki K, Uemura Y, Okamoto S, et al. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs. J Neurosurg 1989; 71: 558-564
56. Toshima M, Kassell NF, Tanaka Y, et al. Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits. Acta Neurochir 1992; 119: 134-138
57. Toyoda K, Faraci FM, Watanabe Y, et al. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res 2000; 87: 818-824
58. Satoh M, Perkins E, Kimura H, et al. Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J Neurosurg 2002; 97: 136-142
59. Katusic ZS, Shepherd JT. Endothelium-derived vasoactive factors: II. Endothelium-dependent contractions. Hypertension 1991; 18 (suppl. III): III86-III92
60. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
61. Yanagisawa M, Masaki T. Endothelin, a novel endothelium-derived peptide: Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 1989; 38: 1877-1883
62. Vane JR, Anggard EE, Bolting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36
63. Cosentino F, Katusic ZS. Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm? Stroke 1994; 25: 904-908
64. Onoda K, Ono S, Ogihara K, et al. Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 1996; 85: 846-852
65. Ohkuma H, Parney I, Megyesi J, et al. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 1999; 90: 1105-1114
66. Lin CL, Jeng AY, Howng SL, et al. Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: Pathogenesis and treatment. Curr Med Chem 2004; 11: 1779-1791
67. Wood MJ, Trulzsch B, Abdelgany A, et al. Therapeutic gene silencing in the nervous system. Hum Mol Gen 2003; 12: R279-R284
68. Fountaine TM, Wood MJ, Wade-Martins R. Delivering RNA interference to the mammalian brain. Curr Gene Ther 2005; 5: 399-410
69. Chen X, Dudgeon N, Shen L, et al. Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Disc Today 2005; 10: 587-593
70. Ono S, Date I, Onoda K, et al. Decoy administration of NF-kappaB into the subarachnoid space for cerebral angiopathy. Hum Cene Ther 1998; 9: 1003-1011
71. Epstein AM, Throckmorton D, Brophy CM. Mitogen-activated protein kinase activation: An alternate signaling pathway for sustained vascular smooth muscle contraction. J Vasc Surg 1997; 26: 337-332
72. Zubkov AY, Ogihara K, Tumu P, et al. Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar artery. J Neurosurg 1999; 90: 1091-1097
73. Zubkov AY, Rollings KS, Parent AD, et al. Mechanism of endothelin-1-induced contraction in rabbit basilar artery. Stroke 2000; 31: 526-533
74. Satoh M, Parent AD, Zhang JH. Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats. Stroke 2002; 33: 775-781
75. Katusic ZS, Milde JH, Cosentino F, et al. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brainstem arteries in dogs. Stroke 1993; 24: 392-399
76. Balicki D, Beutler E. Gene therapy of human disease. Medicine 2002; 81: 69-86
77. Dyer MR, Herrling PL. Progress and potential for gene-based medicines. Mol Ther 2000; 1: 213-224
78. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40
79. Richter M, Iwata A, Nyhuis J, et al. Adeno-associated virus transduction of vascular smooth muscle cells in vivo. Physiol Genom 2000; 2: 117-127
80. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967
81. Liu C, Nath KA, Katusic ZS, et al. Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med 2004; 14: 288-293
82. Gulati R, Jevremovic D, Peterson TE, et al. Autologous culture-modified mononuclear cells confer vascular protection against arterial injury. Circulation 2003; 108: 1520-1526
83. Griese DP, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial progenitor cells into denuded vessels and prosthetic grafts: Implications for cell-based therapy. Circulation 2003; 108: 2710-2715
84. Werner K, Junk S, Laufs U, et al. Intravenous infusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93: 17-24
85. He T, Smith LA, Harrington S, et al. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-2384
86. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228
87. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002; 106: 2019-2025
88. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002; 106: 3009-3017
89. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomized controlled trial. Lancet 2002; 360: 427-435
90. He T, Peterson TE, Holmuhamedov EL, et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004; 24: 2021-2027
91. Dernbach E, Urbich C, Brandes RP, et al. Antioxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress. Blood 2004; 104: 3591-3597
92. He T, Peterson TE, Katusic ZS. Paracrine mitogenic effect of human endothelial progenitor cells: Role of interleukin-8. Am J Physiol Heart Circ Physiol 2005; 289: H968-H972
93. Lu D, Mahmood A, Wang L, et al. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001; 12: 559-563
94. Li Y, Chen J, Wang L, et al. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 2001; 56: 1666-1672
95. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228
96. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-738
97. Herder C, Tonn T, Oostendorp R, et al. Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells. Hypertension 2003; 23: 2266-2272
98. Kong D, Melo LG, Mangi AA, et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004; 109: 1769-1775
99. Onoue H, Tsutsui M, Smith L, et al. Adventitial expression of recombinant endothelial nitric oxide synthase gene reverses vasoconstrictor effect of endothelin-1. J Cereb Blood Flow Metab 1999; 19: 1029-1037
100. Tsutsui M, Onoue H, Iida Y, et al. Aclventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. Am J Physiol 1999; 276: H1846-H1852
101. Tsutsui M, Onoue H, Iida Y, et al. Effects of recombinant eNOS gene expression on reactivity of small cerebral arteries. Am J Physiol Heart Circ Physiol 2000; 278: H420-H427
102. Stoodley M, Weihl CC, Zhang ZD, et al. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 2000; 45: 1195-1203